The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-N-(2-(4-Chlorophenyl)-2-(1H-imidazol-1-yl)ethyl)-4-(3,4-dimethoxystyryl)benzamide ID: ALA4080128
PubChem CID: 137646382
Max Phase: Preclinical
Molecular Formula: C28H26ClN3O3
Molecular Weight: 487.99
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(/C=C/c2ccc(C(=O)NCC(c3ccc(Cl)cc3)n3ccnc3)cc2)cc1OC
Standard InChI: InChI=1S/C28H26ClN3O3/c1-34-26-14-7-21(17-27(26)35-2)4-3-20-5-8-23(9-6-20)28(33)31-18-25(32-16-15-30-19-32)22-10-12-24(29)13-11-22/h3-17,19,25H,18H2,1-2H3,(H,31,33)/b4-3+
Standard InChI Key: YTZLMGTUQRYYSO-ONEGZZNKSA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
8.8633 -3.4694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1583 -3.8780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1583 -4.6952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4492 -5.1038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7401 -4.6952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7401 -3.8780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4492 -3.4694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8633 -2.6522 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5724 -3.8780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0310 -5.1038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3261 -4.6952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6170 -5.1038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6170 -5.9210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9120 -6.3296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2029 -5.9210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2029 -5.1038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9120 -4.6952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2773 -3.4694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9864 -3.8780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6497 -5.1753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3950 -5.9526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5778 -5.9526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3273 -5.1753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9864 -4.6952 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6955 -3.4694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6955 -2.6522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4046 -2.2436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1096 -2.6522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1096 -3.4694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4046 -3.8780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8176 -2.2442 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.4954 -4.6949 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4958 -3.8777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4954 -6.3299 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7875 -5.9216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
1 9 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
5 10 1 0
18 19 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
20 24 1 0
19 24 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
25 30 2 0
19 25 1 0
9 18 1 0
28 31 1 0
16 32 1 0
32 33 1 0
15 34 1 0
34 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 487.99Molecular Weight (Monoisotopic): 487.1663AlogP: 5.74#Rotatable Bonds: 9Polar Surface Area: 65.38Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 6.71CX LogP: 5.37CX LogD: 5.31Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.31Np Likeness Score: -0.91
References 1. Taban IM, Zhu J, DeLuca HF, Simons C.. (2017) Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides., 25 (15): [PMID:28601511 ] [10.1016/j.bmc.2017.05.055 ] 2. Bruno, Robert D RD and Njar, Vincent C O VC. 2007-08-01 Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. [PMID:17544277 ] 3. Taban, Ismail M IM, Zhu, Jinge J, DeLuca, Hector F HF and Simons, Claire C. 2017-08-01 Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides. [PMID:28601511 ]